{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:21:02Z","timestamp":1794324062199,"version":"4.9.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,7]]},"abstract":"<jats:p>Immunosuppressive therapy in decompensated cirrhotic patients with an indication for liver transplantation (LT) is controversial. This study aims to evaluate transplant-free survival rates in patients diagnosed with decompensated autoimmune hepatitis (AIH) with and without immunosuppressants (IS) treatment, and to identify predictors of mortality or LT. We retrospectively analyzed LT-evaluated consecutive patients with decompensated AIH at a single center, between 2013 and 2021. Patients were categorized into IS (IS Group) and non-IS (No IS Group). Survival curves for the 2 groups were evaluated using the Kaplan\u2013Meier method, and differences were compared using the Log-rank test. Multiple regression analysis was conducted using Cox test. A total of 125 consecutive patients (mean age: 36.4 years; 81.6% female) were evaluated. The median transplant-free survival in the IS Group (72\/125) were 22.6 months vs 6.57 months in the No IS Group (53\/125) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.002). Cox-regression analysis revealed associations between moderate\/severe ascites (hazard ratio [HR]\u2005=\u20052.37, 95% CI\u2005=\u20051.48\u20133.80, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005&lt;.001) and MELD-Na (HR\u2005=\u20051.12, 95% CI\u2005=\u20051.08\u20131.16, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005&lt;.001) with transplantation or death, while immunosuppression treatment acted protectively (HR\u2005=\u20050.55, 95% CI\u2005=\u20050.86\u20130.85, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.008). Analyzing patients with MELD &gt;22 (27\/125) showed a loss of IS protective effect (OR\u2005=\u20050.45, 95% CI\u2005=\u20050.17\u20131.20, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.11), and the presence of moderate\/severe ascites increased the risk of death\/LT (HR\u2005=\u20055.86, 95% CI\u2005=\u20051.26\u201327.2, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.02). Autoimmune decompensated cirrhosis is associated with high overall mortality, and IS improves the transplant-free survival rate. In patients with MELD-Na &gt;22, treatment ceases to be beneficial, especially if they have moderate\/severe ascites. These patients, if receiving immunosuppression, may be disadvantaged in the possibility of accessing LT.<\/jats:p>","DOI":"10.1097\/md.0000000000041378","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:00:35Z","timestamp":1739217635000},"page":"e41378","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Immunosuppressive treatment in autoimmune decompensated cirrhosis, when to say enough: A retrospective analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-7213","authenticated-orcid":false,"given":"Manuel","family":"Barbero","sequence":"first","affiliation":[{"name":"Liver Transplant Unit, Hospital El Cruce de Florencio Varela, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Burgos","sequence":"additional","affiliation":[{"name":"Liver Transplant Unit, Hospital El Cruce de Florencio Varela, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Roca","sequence":"additional","affiliation":[{"name":"Liver Transplant Unit, Hospital El Cruce de Florencio Varela, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Navarro","sequence":"additional","affiliation":[{"name":"Liver Transplant Unit, Hospital El Cruce de Florencio Varela, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cairo","sequence":"additional","affiliation":[{"name":"Liver Transplant Unit, Hospital El Cruce de Florencio Varela, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250210","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4254\/wjh.v8.i28.1157","article-title":"Cirrhosis and autoimmune liver disease: current understanding.","volume":"8","author":"Liberal","year":"2016","journal-title":"World J Hepatol"},{"key":"R2-20250210","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review.","volume":"41","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"R3-20250210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.","volume":"40","author":"Cook","year":"1971","journal-title":"Q J Med"},{"key":"R4-20250210","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jhep.2017.11.020","article-title":"Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.","volume":"68","author":"Hartl","year":"2018","journal-title":"J Hepatol"},{"key":"R5-20250210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.gastrohep.2010.10.003","article-title":"Regresi\u00f3n histol\u00f3gica de la fibrosis hep\u00e1tica con tratamiento inmunosupresor en hepatitis autoinmune.","volume":"34","author":"Valera","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"R6-20250210","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/apt.12592","article-title":"The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.","volume":"39","author":"Czaja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R7-20250210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","article-title":"Reversibility of hepatic fibrosis in autoimmune hepatitis.","volume":"127","author":"Dufour","year":"1997","journal-title":"Ann Intern Med"},{"key":"R8-20250210","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis.","volume":"51","author":"Garcia-Tsao","year":"2010","journal-title":"Hepatology"},{"key":"R9-20250210","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.","volume":"32","author":"Zipprich","year":"2012","journal-title":"Liver Int"},{"key":"R10-20250210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"R11-20250210","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25739","article-title":"Longterm survival after liver transplantation for autoimmune hepatitis: results from the European Liver Transplant Registry.","volume":"26","author":"Heinemann","year":"2020","journal-title":"Liver Transpl"},{"key":"R12-20250210","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/lt.23704","article-title":"Liver transplantation and autoimmune liver diseases.","volume":"19","author":"Liberal","year":"2013","journal-title":"Liver Transpl"},{"key":"R13-20250210","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis.","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"R14-20250210","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.dld.2020.04.012","article-title":"Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis.","volume":"52","author":"Gerussi","year":"2020","journal-title":"Dig Liver Dis"},{"key":"R15-20250210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/liv.13458","article-title":"Autoimmune hepatitis: from current knowledge and clinical practice to future research agenda.","volume":"38","author":"Sebode","year":"2018","journal-title":"Liver Int"},{"key":"R16-20250210","doi-asserted-by":"crossref","first-page":"102280","DOI":"10.1016\/j.eclinm.2023.102280","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970\u20132022: a systematic review and meta-analysis.","volume":"65","author":"Hahn","year":"2023","journal-title":"EClinicalMedicine"},{"key":"R17-20250210","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jgh.14746","article-title":"Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population.","volume":"34","author":"Lv","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-20250210","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1665-2681(19)31027-0","article-title":"Liver transplantation for autoimmune hepatitis in Peru: outcomes and recurrence.","volume":"11","author":"Padilla","year":"2012","journal-title":"Ann Hepatol"},{"key":"R19-20250210","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.aohep.2018.11.003","article-title":"Liver transplantation in adults with acute liver failure: outcomes from the Argentinean Transplant Registry.","volume":"18","author":"Mendizabal","year":"2019","journal-title":"Ann Hepatol"},{"key":"R20-20250210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/liv.15829","article-title":"The evolving phenotype of autoimmune hepatitis across the millennium: the 40-year experience of a referral centre in Italy.","volume":"44","author":"Ferronato","year":"2024","journal-title":"Liver Int"},{"key":"R21-20250210","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly.","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"},{"key":"R22-20250210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cgh.2006.10.011","article-title":"Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis.","volume":"5","author":"Abe","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R23-20250210","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","article-title":"Clinicopathological features of severe and fulminant forms of autoimmune hepatitis.","volume":"46","author":"Yasui","year":"2011","journal-title":"J Gastroenterol"},{"key":"R24-20250210","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study.","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"R25-20250210","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short-and long-term outcome in patients with autoimmune hepatitis.","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"R26-20250210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"R27-20250210","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide.","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"R28-20250210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1665-2681(19)30899-3","article-title":"The impact of bacterial infections on survival of patients with decompensated cirrhosis.","volume":"13","author":"Strauss","year":"2014","journal-title":"Ann Hepatol"},{"key":"R29-20250210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1556\/oh.2007.27882","article-title":"Bacterial infections in cirrhosis.","volume":"148","author":"Papp","year":"2007","journal-title":"Orv Hetil"},{"key":"R30-20250210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jgh3.12451","article-title":"Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids.","volume":"5","author":"Sharma","year":"2021","journal-title":"JGH Open"},{"key":"R31-20250210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"R32-20250210","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/00365521.2016.1157887","article-title":"Infections complicating severe alcoholic hepatitis: enterococcus species represent the most frequently identified pathogen.","volume":"51","author":"Beisel","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"R33-20250210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/liv.12939","article-title":"Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials.","volume":"36","author":"Hmoud","year":"2016","journal-title":"Liver Int"},{"key":"R34-20250210","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","article-title":"The management of autoimmune hepatitis patients with decompensated cirrhosis: real-world experience and a comprehensive review.","volume":"52","author":"Wang","year":"2017","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:00:46Z","timestamp":1739217646000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041378","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}